{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:14:31Z","timestamp":1787004871405,"version":"build-2736575974"},"reference-count":97,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute exacerbations of chronic obstructive pulmonary disease (ECOPD) are pivotal events that accelerate lung function decline, impair quality of life, and increase the risk of hospitalization and mortality. Beyond episodic airway deterioration, ECOPD should be conceptualized as a systemic inflammatory syndrome driven by dysregulated responses to infectious or environmental triggers. Among inflammatory biomarkers, C-reactive protein (CRP) is the most extensively studied in ECOPD because of its rapid kinetics, wide availability, and clinical accessibility. This narrative review aims to summarize the diagnostic, therapeutic, and prognostic role of CRP in ECOPD. CRP levels rise sharply during exacerbations, particularly in pneumonic events, supporting diagnostic stratification and differentiation from non-bacterial or eosinophilic phenotypes. When integrated with clinical assessment, CRP improves diagnostic accuracy and informs antibiotic stewardship; CRP-guided strategies have been shown to reduce unnecessary antibiotic use without compromising clinical outcomes. Elevated CRP at presentation is associated with greater exacerbation severity, increased need for ventilatory support, and longer hospital stay. Persistently elevated CRP at discharge is linked to early relapse and readmission, while higher levels have also been associated with thromboembolic and cardiovascular risk, highlighting the systemic consequences of ECOPD. Despite these advantages, CRP is inherently nonspecific, influenced by comorbidities and timing of measurement, and optimal thresholds vary across clinical settings. CRP is a robust and accessible biomarker that provides valuable diagnostic, therapeutic, and prognostic information in ECOPD. Its incorporation into routine clinical practice can improve patient stratification, support antibiotic stewardship, and enhance monitoring of individuals at high risk of adverse outcomes. Future advances are likely to rely on longitudinal interpretation of CRP and its integration into multimarker panels and predictive models, combined with clinical variables and digital health data, to enable phenotype-driven management and precision medicine approaches in ECOPD.<\/jats:p>","DOI":"10.1055\/a-2818-1526","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:08:27Z","timestamp":1771891707000},"page":"268-275","source":"Crossref","is-referenced-by-count":3,"title":["Inflammatory Response in Exacerbations of COPD: Clinical and Predictive Roles of C-Reactive Protein"],"prefix":"10.1055","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1283-4718","authenticated-orcid":false,"given":"Giulia","family":"Sartori","sequence":"additional","affiliation":[{"name":"Respiratory Medicine Unit, Department of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5707-775X","authenticated-orcid":false,"given":"Alberto","family":"Fantin","sequence":"additional","affiliation":[{"name":"Respiratory Medicine Unit, Department of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy"},{"name":"Department of Pulmonology, S. Maria della Misericordia University Hospital, Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Sartori","sequence":"additional","affiliation":[{"name":"Respiratory Medicine Unit, Department of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7298-7084","authenticated-orcid":false,"given":"Ernesto","family":"Crisafulli","sequence":"additional","affiliation":[{"name":"Respiratory Medicine Unit, Department of Medicine, University of Verona and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"issue":"05","key":"ref1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S2213-2600(21)00511-7","article-title":"Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis","volume":"10","author":"D Adeloye","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/S2213-2600(24)00413-2","article-title":"GOLD COPD report: 2025 update","volume":"13","author":"P Venkatesan","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"06","key":"ref3","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/resp.14041","article-title":"Chronic obstructive pulmonary disease exacerbation fundamentals: diagnosis, treatment, prevention and disease impact","volume":"26","author":"M MacLeod","year":"2021","journal-title":"Respirology"},{"issue":"03","key":"ref4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1183\/13993003.00791-2016","article-title":"Management of COPD exacerbations: a European Respiratory Society\/American Thoracic Society guideline","volume":"49","author":"J A Wedzicha","year":"2017","journal-title":"Eur Respir J"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1164\/rccm.202108-1819PP","article-title":"An updated definition and severity classification of chronic obstructive pulmonary disease exacerbations: the Rome proposal","volume":"204","author":"B R Celli","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40248-018-0149-0","article-title":"Management of severe acute exacerbations of COPD: an updated narrative review","volume":"13","author":"E Crisafulli","year":"2018","journal-title":"Multidiscip Respir Med"},{"issue":"06","key":"ref7","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.chest.2023.07.021","article-title":"Association between Rome classification among hospitalized patients with COPD exacerbations and short-term and intermediate-term outcomes","volume":"164","author":"E Crisafulli","year":"2023","journal-title":"Chest"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1183\/23120541.00838-2023","article-title":"Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65\u2009945 individual patients","volume":"10","author":"K Waeijen-Smit","year":"2024","journal-title":"ERJ Open Res"},{"issue":"06","key":"ref9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/17476348.2024.2375426","article-title":"Factors associated with risk of death in hospitalized patients for exacerbation of chronic obstructive pulmonary disease: an updated scoping review","volume":"18","author":"R Caprino","year":"2024","journal-title":"Expert Rev Respir Med"},{"issue":"08","key":"ref10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/17476348.2019.1635459","article-title":"Hospitalized acute exacerbations of chronic obstructive pulmonary disease: which patients may have a negative clinical outcome?","volume":"13","author":"E Crisafulli","year":"2019","journal-title":"Expert Rev Respir Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","article-title":"COPD exacerbations: defining their cause and prevention","volume":"370","author":"J A Wedzicha","year":"2007","journal-title":"Lancet"},{"issue":"10","key":"ref12","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1164\/rccm.200506-859OC","article-title":"Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations","volume":"173","author":"A Papi","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"13","key":"ref13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/jcm13133855","article-title":"CRP, fibrinogen, white blood cells, and blood cell indices as prognostic biomarkers of future COPD exacerbation frequency: the TIE cohort study","volume":"13","author":"J Ellingsen","year":"2024","journal-title":"J Clin Med"},{"key":"ref14","first-page":"21","article-title":"Exacerbations of COPD","volume":"11","author":"I D Pavord","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"116","key":"ref15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1183\/09059180.00002610","article-title":"Impact of exacerbations on COPD","volume":"19","author":"A Anzueto","year":"2010","journal-title":"Eur Respir Rev"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S2213-2600(22)00388-5","article-title":"Moving the pathway goalposts: COPD as an immune-mediated inflammatory disease","volume":"10","author":"S P Cass","year":"2022","journal-title":"Lancet Respir Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"975914","DOI":"10.3389\/fimmu.2022.975914","article-title":"Epithelial cell alarmin cytokines: frontline mediators of the asthma inflammatory response","volume":"13","author":"M Duchesne","year":"2022","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"151S","DOI":"10.1378\/chest.121.5_suppl.151S","article-title":"Neutrophils and the pathogenesis of COPD","volume":"121","author":"R A Stockley","year":"2002","journal-title":"Chest"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease","volume":"138","author":"P J Barnes","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jaci.2025.04.011","article-title":"Innate immune reprogramming in circulating neutrophils of COPD patients","volume":"156","author":"B Mariotti","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"01","key":"ref21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12931-021-01718-8","article-title":"Defective monocyte-derived macrophage phagocytosis is associated with exacerbation frequency in COPD","volume":"22","author":"R Singh","year":"2021","journal-title":"Respir Res"},{"issue":"05","key":"ref22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1183\/09031936.00036709","article-title":"Defective macrophage phagocytosis of bacteria in COPD","volume":"35","author":"A E Taylor","year":"2010","journal-title":"Eur Respir J"},{"issue":"11","key":"ref23","doi-asserted-by":"crossref","first-page":"e1001178","DOI":"10.1371\/journal.ppat.1001178","article-title":"Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium","volume":"6","author":"L Slater","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3389\/fimmu.2020.01205","article-title":"Mechanisms of virus-induced airway immunity dysfunction in the pathogenesis of COPD disease, progression, and exacerbation","volume":"11","author":"H Guo-Parke","year":"2020","journal-title":"Front Immunol"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1183\/23120541.00836-2020","article-title":"High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis","volume":"7","author":"A Chakrabarti","year":"2021","journal-title":"ERJ Open Res"},{"issue":"06","key":"ref26","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers","volume":"184","author":"M Bafadhel","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1164\/rccm.201410-1861OC","article-title":"IL-17A is elevated in end-stage chronic obstructive pulmonary disease and contributes to cigarette smoke-induced lymphoid neogenesis","volume":"191","author":"A B Roos","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"01","key":"ref28","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1378\/chest.12-2664","article-title":"Oxidative stress in COPD","volume":"144","author":"P A Kirkham","year":"2013","journal-title":"Chest"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ccm.2013.10.004","article-title":"Cellular and molecular mechanisms of chronic obstructive pulmonary disease","volume":"35","author":"P J Barnes","year":"2014","journal-title":"Clin Chest Med"},{"issue":"02","key":"ref30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/15412550801941349","article-title":"COPD as a systemic disease","volume":"5","author":"A Agusti","year":"2008","journal-title":"COPD"},{"issue":"07","key":"ref31","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/thx.2003.019588","article-title":"Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis","volume":"59","author":"W Q Gan","year":"2004","journal-title":"Thorax"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"G S Hotamisligil","year":"2006","journal-title":"Nature"},{"issue":"08","key":"ref33","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1164\/rccm.200604-506OC","article-title":"Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease","volume":"174","author":"J R Hurst","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2147\/COPD.S410387","article-title":"Prognostic biomarkers based on proteomic technology in COPD: a recent review","volume":"18","author":"H Fang","year":"2023","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"22","key":"ref35","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMra0800353","article-title":"Infection in the pathogenesis and course of chronic obstructive pulmonary disease","volume":"359","author":"S Sethi","year":"2008","journal-title":"N Engl J Med"},{"issue":"13","key":"ref36","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJMra1900500","article-title":"Update on clinical aspects of chronic obstructive pulmonary disease","volume":"381","author":"B R Celli","year":"2019","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-reactive protein at sites of inflammation and infection","volume":"9","author":"N R Sproston","year":"2018","journal-title":"Front Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1425168","DOI":"10.3389\/fimmu.2024.1425168","article-title":"C-reactive protein: structure, function, regulation, and role in clinical diseases","volume":"15","author":"H H Zhou","year":"2024","journal-title":"Front Immunol"},{"issue":"47","key":"ref39","doi-asserted-by":"crossref","first-page":"48487","DOI":"10.1074\/jbc.R400025200","article-title":"C-reactive protein","volume":"279","author":"S Black","year":"2004","journal-title":"J Biol Chem"},{"issue":"143","key":"ref40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1183\/16000617.0070-2016","article-title":"C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis","volume":"26","author":"G Leuzzi","year":"2017","journal-title":"Eur Respir Rev"},{"issue":"01","key":"ref41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/thx.2005.041996","article-title":"Raised CRP levels mark metabolic and functional impairment in advanced COPD","volume":"61","author":"R Broekhuizen","year":"2006","journal-title":"Thorax"},{"issue":"04","key":"ref42","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1378\/chest.13-0488","article-title":"Pneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristics","volume":"144","author":"A Huerta","year":"2013","journal-title":"Chest"},{"issue":"10","key":"ref43","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1164\/rccm.201810-1860SO","article-title":"Chronic obstructive pulmonary disease biomarkers and their interpretation","volume":"199","author":"R A Stockley","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"04","key":"ref44","first-page":"698","article-title":"Blood and sputum biomarkers in COPD and asthma: a review","volume":"20","author":"G Paone","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"02","key":"ref45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1183\/23120541.00983-2020","article-title":"Endothelial dysfunction in COPD: a systematic review and meta-analysis of studies using different functional assessment methods","volume":"7","author":"M P Theodorakopoulou","year":"2021","journal-title":"ERJ Open Res"},{"issue":"01","key":"ref46","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12931-025-03405-4","article-title":"Alterations in clot microstructure in acute exacerbations of COPD","volume":"26","author":"S Pillai","year":"2025","journal-title":"Respir Res"},{"issue":"06","key":"ref47","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1055\/s-0040-1702196","article-title":"Pneumonic versus nonpneumonic exacerbations of chronic obstructive pulmonary disease","volume":"41","author":"E Crisafulli","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"issue":"09","key":"ref48","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1164\/rccm.202209-1795CI","article-title":"Differential diagnosis of suspected chronic obstructive pulmonary disease exacerbations in the acute care setting: best practice","volume":"207","author":"B R Celli","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"04","key":"ref49","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1378\/chest.12-1684","article-title":"Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD","volume":"143","author":"E Crisafulli","year":"2013","journal-title":"Chest"},{"issue":"10","key":"ref50","first-page":"15","article-title":"The emerging biomarkers in chronic obstructive pulmonary disease: a narrative review","volume":"15","author":"K M Phillips","year":"2025","journal-title":"Diagnostics (Basel)"},{"issue":"07","key":"ref51","doi-asserted-by":"crossref","first-page":"e0158843","DOI":"10.1371\/journal.pone.0158843","article-title":"A systematic review of diagnostic biomarkers of COPD exacerbation","volume":"11","author":"Y W Chen","year":"2016","journal-title":"PLoS One"},{"issue":"05","key":"ref52","doi-asserted-by":"crossref","first-page":"e069453","DOI":"10.1136\/bmjopen-2022-069453","article-title":"Point-of-care measurement of C-reactive protein promotes de-escalation of treatment decisions and strengthens the perceived clinical confidence of physicians in out-of-hours outpatient emergency medical services","volume":"13","author":"A Matthes","year":"2023","journal-title":"BMJ Open"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"108182","DOI":"10.1016\/j.rmed.2025.108182","article-title":"Clinical phenotypes predict exacerbations of COPD: the TIE cohort study","volume":"244","author":"J Ellingsen","year":"2025","journal-title":"Respir Med"},{"issue":"01","key":"ref54","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41479-023-00106-8","article-title":"Innate immune responses in pneumonia","volume":"15","author":"F T Korkmaz","year":"2023","journal-title":"Pneumonia"},{"issue":"01","key":"ref55","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12890-022-01958-4","article-title":"Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis","volume":"22","author":"G Hoult","year":"2022","journal-title":"BMC Pulm Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.2147\/COPD.S90330","article-title":"The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia","volume":"10","author":"D Duman","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.2147\/JIR.S508048","article-title":"Combined inflammatory markers for predicting acute exacerbations in chronic obstructive pulmonary disease with respiratory failure","volume":"18","author":"X H Zhang","year":"2025","journal-title":"J Inflamm Res"},{"issue":"12","key":"ref58","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"M B Pepys","year":"2003","journal-title":"J Clin Invest"},{"issue":"02","key":"ref59","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2217\/bmm.15.87","article-title":"Implications of the inflammatory response for the identification of biomarkers of chronic obstructive pulmonary disease","volume":"10","author":"J L Lopez-Campos","year":"2016","journal-title":"Biomarkers Med"},{"issue":"03","key":"ref60","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1378\/chest.12-0938","article-title":"Cardiovascular disease in COPD: mechanisms","volume":"143","author":"J D Maclay","year":"2013","journal-title":"Chest"},{"issue":"06","key":"ref61","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s12325-024-02855-4","article-title":"Implications of cardiopulmonary risk for the management of COPD: a narrative review","volume":"41","author":"D Singh","year":"2024","journal-title":"Adv Ther"},{"issue":"05","key":"ref62","doi-asserted-by":"crossref","first-page":"e37483","DOI":"10.1371\/journal.pone.0037483","article-title":"Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype","volume":"7","author":"A Agust\u00ed","year":"2012","journal-title":"PLoS One"},{"issue":"03","key":"ref63","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1378\/chest.10-2948","article-title":"The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study","volume":"140","author":"V Kim","year":"2011","journal-title":"Chest"},{"issue":"12","key":"ref64","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"J R Hurst","year":"2010","journal-title":"N Engl J Med"},{"issue":"05","key":"ref65","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/17476348.2020.1732823","article-title":"How may we improve clinical outcomes for patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease? A narrative review about possible therapeutic and preventive strategies","volume":"14","author":"E Crisafulli","year":"2020","journal-title":"Expert Rev Respir Med"},{"issue":"03","key":"ref67","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1183\/09031936.00092506","article-title":"Inflammatory changes, recovery and recurrence at COPD exacerbation","volume":"29","author":"W R Perera","year":"2007","journal-title":"Eur Respir J"},{"issue":"05","key":"ref68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1183\/13993003.02014-2018","article-title":"CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions","volume":"53","author":"H J Prins","year":"2019","journal-title":"Eur Respir J"},{"issue":"01","key":"ref69","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/15412555.2015.1057276","article-title":"Predicting in-hospital treatment failure (\u2264 7 days) in patients with COPD exacerbation using antibiotics and systemic steroids","volume":"13","author":"E Crisafulli","year":"2016","journal-title":"COPD"},{"issue":"06","key":"ref70","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s11739-015-1228-2","article-title":"Correlation between decrease of CRP and resolution of airway inflammatory response, improvement of health status, and clinical outcomes during severe acute exacerbation of chronic obstructive pulmonary disease","volume":"10","author":"Y Liang","year":"2015","journal-title":"Intern Emerg Med"},{"issue":"04","key":"ref71","doi-asserted-by":"crossref","first-page":"100271","DOI":"10.1016\/j.opresp.2023.100271","article-title":"Prognostic usefulness of basic analytical data in chronic obstructive pulmonary disease exacerbation","volume":"5","author":"S Mart\u00ednez-Gestoso","year":"2023","journal-title":"Open Respir Arch"},{"issue":"03","key":"ref72","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1164\/rccm.200605-713OC","article-title":"C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease","volume":"175","author":"M Dahl","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"ref73","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/thx.2006.059808","article-title":"C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease","volume":"61","author":"S F Man","year":"2006","journal-title":"Thorax"},{"issue":"156","key":"ref74","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1183\/16000617.0166-2019","article-title":"Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis","volume":"29","author":"J S Alqahtani","year":"2020","journal-title":"Eur Respir Rev"},{"issue":"01","key":"ref75","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/s12890-024-03399-7","article-title":"Risk factors for prolonged hospitalization as a marker for difficult-to-manage exacerbations of chronic obstructive lung disease (COPD): the DiMECO Study","volume":"24","author":"D Esenda\u011fl\u0131","year":"2024","journal-title":"BMC Pulm Med"},{"issue":"01","key":"ref76","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12931-018-0951-4","article-title":"Clinical variables predicting the risk of a hospital stay for longer than 7\u2009days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study","volume":"19","author":"E Crisafulli","year":"2018","journal-title":"Respir Res"},{"issue":"03","key":"ref77","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3109\/15412555.2014.933954","article-title":"C-reactive protein at discharge, diabetes mellitus and \u2265 1 hospitalization during previous year predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"12","author":"E Crisafulli","year":"2015","journal-title":"COPD"},{"issue":"03","key":"ref78","doi-asserted-by":"crossref","first-page":"e0150737","DOI":"10.1371\/journal.pone.0150737","article-title":"Readmission for acute exacerbation within 30 days of discharge is associated with a subsequent progressive increase in mortality risk in COPD patients: a long-term observational study","volume":"11","author":"M Guerrero","year":"2016","journal-title":"PLoS One"},{"issue":"01","key":"ref79","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1186\/s40001-025-03042-z","article-title":"Prediction of 12-month exacerbation-related readmission in hospitalized patients with COPD: a single-center study in China","volume":"30","author":"C Zhang","year":"2025","journal-title":"Eur J Med Res"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1611981","DOI":"10.3389\/fmed.2025.1611981","article-title":"Association between nutritional risk and CRP levels in patients with acute exacerbation of chronic obstructive pulmonary disease","volume":"12","author":"P Liang","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"106094","DOI":"10.1016\/j.rmed.2020.106094","article-title":"Acute exacerbations of COPD are associated with a prothrombotic state through platelet-monocyte complexes, endothelial activation and increased thrombin generation","volume":"171","author":"L N van der Vorm","year":"2020","journal-title":"Respir Med"},{"issue":"04","key":"ref82","doi-asserted-by":"crossref","first-page":"439","DOI":"10.5551\/jat.65177","article-title":"Inflammatory biomarkers as predictors of symptomatic venous thromboembolism in hospitalized patients with AECOPD: a multicenter cohort study","volume":"32","author":"J Zeng","year":"2025","journal-title":"J Atheroscler Thromb"},{"issue":"05","key":"ref83","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1378\/chest.09-2029","article-title":"Increased risk of myocardial infarction and stroke following exacerbation of COPD","volume":"137","author":"G C Donaldson","year":"2010","journal-title":"Chest"},{"issue":"01","key":"ref84","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12931-025-03356-w","article-title":"Toward precision medicine in COPD: phenotypes, endotypes, biomarkers, and treatable traits","volume":"26","author":"C Xie","year":"2025","journal-title":"Respir Res"},{"issue":"04","key":"ref85","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0954-6111(98)90515-7","article-title":"Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease","volume":"92","author":"D Dev","year":"1998","journal-title":"Respir Med"},{"issue":"05","key":"ref86","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.cmi.2024.12.004","article-title":"Procalcitonin-guided use of antibiotic in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized clinical trial","volume":"31","author":"W Sheng","year":"2025","journal-title":"Clin Microbiol Infect"},{"issue":"02","key":"ref87","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1513\/AnnalsATS.201208-043OC","article-title":"Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease","volume":"10","author":"A Singanayagam","year":"2013","journal-title":"Ann Am Thorac Soc"},{"issue":"10","key":"ref88","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1164\/rccm.201110-1792OC","article-title":"Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease","volume":"185","author":"B R Celli","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"02","key":"ref89","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1803185","article-title":"C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations","volume":"381","author":"C C Butler","year":"2019","journal-title":"N Engl J Med"},{"issue":"01","key":"ref90","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","article-title":"Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis","volume":"18","author":"P Schuetz","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"02","key":"ref91","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1086\/421997","article-title":"Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis","volume":"39","author":"L Simon","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1741-7015-9-107","article-title":"Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future","volume":"9","author":"P Schuetz","year":"2011","journal-title":"BMC Med"},{"issue":"02","key":"ref93","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of chronic airway diseases","volume":"47","author":"A Agusti","year":"2016","journal-title":"Eur Respir J"},{"issue":"12","key":"ref94","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/jcm5120108","article-title":"Monitoring of physiological parameters to predict exacerbations of chronic obstructive pulmonary disease (COPD): a systematic review","volume":"5","author":"A M Al Rajeh","year":"2016","journal-title":"J Clin Med"},{"issue":"07","key":"ref95","first-page":"CD007718","article-title":"Telehealthcare for chronic obstructive pulmonary disease","volume":"2011","author":"S McLean","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"03","key":"ref96","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1183\/23120541.00198-2021","article-title":"MULTI-PHACET: multidimensional clinical phenotyping of hospitalised acute COPD exacerbations","volume":"7","author":"M I MacDonald","year":"2021","journal-title":"ERJ Open Res"},{"issue":"03","key":"ref97","first-page":"24","article-title":"Applying next-generation sequencing and multi-omics in chronic obstructive pulmonary disease","volume":"24","author":"P Y Tiew","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"11","key":"ref98","doi-asserted-by":"crossref","first-page":"e034592","DOI":"10.1136\/bmjopen-2019-034592","article-title":"Endotype-driven prediction of acute exacerbations in chronic obstructive pulmonary disease (EndAECOPD): protocol for a prospective cohort study","volume":"9","author":"W Xiao","year":"2019","journal-title":"BMJ Open"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2818-1526.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:48:27Z","timestamp":1781218107000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2818-1526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":97,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2026,6,11]]},"published-print":{"date-parts":[[2026,6]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2818-1526","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,23]]},"published":{"date-parts":[[2026,2,23]]}}}